首页> 外文期刊>Medicine. >Diagnostic Value of Serum IgG4 for IgG4-Related Disease: A PRISMA-compliant Systematic Review and Meta-analysis
【24h】

Diagnostic Value of Serum IgG4 for IgG4-Related Disease: A PRISMA-compliant Systematic Review and Meta-analysis

机译:血清IgG4对IgG4相关疾病的诊断价值:符合PRISMA的系统评价和荟萃分析

获取原文
           

摘要

Many studies about serum IgG4 for the diagnosis of IgG4-related disease (IgG4-RD) have been reported. However, these studies had relatively small sample sizes and the diagnostic accuracy values varied much between them. The aim of this study was to perform a meta-analysis to evaluate the diagnostic value of serum IgG4 for IgG4-RD. We conducted a search of relevant articles using MEDLINE, EMBASE, Web of Science, SCOPUS, and Cochrane Library databases published before December 2015. Studies those assessed the diagnostic accuracy of serum IgG4 for IgG4-RD and those provided the cut-off value for serum IgG4 were included. Data were synthesized using the random-effect model. Statistical analysis was performed using STATA with the MIDAS module and Meta-DiSc 1.4 software. A total of 9 case-control studies were analyzed, which included 1235 patients with IgG4-RD and 5696 overall controls. The pooled estimate, for a cut-off value ranged from 135 to 144?mg/dL, produced a sensitivity of 87.2% (95% CI, 85.2–89.0%) and a specificity of 82.6% (95% CI, 81.6–83.6%). The positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR) were 6.48 (95% CI, 3.98–10.57), 0.14 (95% CI, 0.09–0.21), and 45.15 (95% CI, 23.41–87.06), respectively. The area under the curve (AUC) of the summary receiver operating characteristic curve (SROC) was 0.94 (0.92–0.96). When a cut-off value of 2-fold the upper limit of normal was used (ranged from 270 to 280?mg/dL), the pooled sensitivity was 63% (95% CI, 60.0–66.0%), and the specificity was 94.8% (95% CI, 94.1–95.4%). The PLR, NLR, and DOR were 13.3 (95% CI, 7.39–24.0), 0.41 (95% CI, 0.29–0.58) and 33.42 (95% CI, 13.88–80.43), respectively. The AUC of the SROC was 0.92 (0.90–0.94). Only a relatively small number of studies were included, and significant heterogeneity was observed in this meta-analysis. Serum IgG4 is a modestly effective marker to diagnose IgG4-RD. Doubling the cut-off value for IgG4 could not improve the overall test characteristics. A high specificity inevitably accompanies with a significant sacrifice in sensitivity.
机译:已经报道了许多关于血清IgG4用于诊断IgG4相关疾病(IgG4-RD)的研究。但是,这些研究的样本量相对较小,并且诊断准确性值之间存在很大差异。这项研究的目的是进行荟萃分析,以评估血清IgG4对IgG4-RD的诊断价值。我们使用2015年12月之前发布的MEDLINE,EMBASE,Web of Science,SCOPUS和Cochrane图书馆数据库进行了相关文章的检索。研究评估了血清IgG4对IgG4-RD的诊断准确性,并提供了血清截止值包括IgG4。使用随机效应模型合成数据。使用带有MIDAS模块和Meta-DiSc 1.4软件的STATA进行统计分析。总共分析了9个病例对照研究,其中包括1235例IgG4-RD患者和5696例总体对照。合并估计值的截断值范围为135至144?mg / dL,灵敏度为87.2%(95%CI,85.2-89.0%),特异性为82.6%(95%CI,81.6-83.6)。 %)。正似然比(PLR),负似然比(NLR)和诊断比值比(DOR)为6.48(95%CI,3.98–10.57),0.14(95%CI,0.09–0.21)和45.15(95%) CI,23.41-87.06)。摘要接收器工作特性曲线(SROC)的曲线下面积(AUC)为0.94(0.92-0.96)。当使用临界值上限的2倍(从270到280?mg / dL范围)时,合并的敏感性为63%(95%CI,60.0-66.0%),特异性为94.8%(95%CI,94.1–95.4%)。 PLR,NLR和DOR分别为13.3(95%CI,7.39-24.0),0.41(95%CI,0.29-0.58)和33.42(95%CI,13.88-80.43)。 SROC的AUC为0.92(0.90-0.94)。仅纳入了相对较少的研究,并且在该荟萃分析中观察到了显着的异质性。血清IgG4是诊断IgG4-RD的适度有效标志物。将IgG4的临界值加倍不能改善整体测试特性。高特异性不可避免地伴随着敏感性的显着牺牲。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号